ER-stressed MSC displayed more effective immunomodulation in RA CD4⁺CXCR5⁺ICOS⁺ follicular helper-like T cells through higher PGE2 binding with EP2/EP4

References

• Hetland ML, Østergaard M, Ejbjerg B, Jacobsen S, Stengaard-Pedersen K, Junker P, et al. Short-and long-term efficacy of intraarticular injections with betamethasome as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP. Ann Rheum Dis. 2012;71(6):851–6.
   PubMed Web of Science ®Google Scholar
• Feng X, Wang D, Chen J, Lu L, Hua B, Li X, et al. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS One. 2012;7(12):e51982.
   PubMed Web of Science ®Google Scholar
• Ueno H, Banchereau J, Vinuesa CG. Pathophysiology of T follicular helper cells in humans and mice. Nat Immunol. 2015;16(2):142–52.
   PubMed Web of Science ®Google Scholar
• Quinn JL, Kumar G, Agasing A, Ko RM, Axtell RC. Role of TFH cells in promoting T helper 17-induced neuro inflammation. Front Immunol. 2018;9:382.
   PubMed Web of Science ®Google Scholar
• Liu R, Wu Q, Su D, Che N, Chen H, Geng L, et al. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis. Arthritis Res Ther. 2012;14(6):R255.
   PubMed Web of Science ®Google Scholar
• Ma J, Zhu C, Ma B, Tian J, Baidoo SE, Mao C, et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol. 2012;2012:1.
   Google Scholar
• Fukuyo S, Nakayamada S, Iwata S, Kubo S, Saito K, Tanaka Y, et al. Abatacept therapy reduces CD28 + CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2017;35(4):562–70.
   PubMed Web of Science ®Google Scholar
• Contreras RA, Figueroa FE, Djouad F, Luz-Crawford P. Mesenchymal stem cells regulate the innate and adaptive immune responses dampening arthritis progression. Stem Cells Int. 2016;2016:1.
   Web of Science ®Google Scholar
• Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D, et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004;103(12):4619–21.
   PubMed Web of Science ®Google Scholar
• English K, French A, Wood KJ. Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell. 2010;7(4):431–42.
   PubMed Web of Science ®Google Scholar
• Najar M, Raicevic G, Kazan HF, De Bruyn C, Bron D, Toungouz M, et al. Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Rev Rep. 2012;8(4):1188–98.
   PubMed Web of Science ®Google Scholar
• Solchaga LA, Zale EA. Prostaglandin E2: a putative potency indicator of the immunosuppressive activity of human mesenchymal stem cells. Am J Stem Cells. 2012;1:138–45.
   PubMedGoogle Scholar
• Zhang Z, Feng R, Niu L, Huang S, Deng W, Shi B, et al. Human umbilical cord mesenchymal stem cells inhibit T follicular helper cell expansion through the activation of iNOS in lupus-prone B6.MRL-Faslpr mice. Cell Transplant. 2017;26(6):1031–42.
   PubMed Web of Science ®Google Scholar
• Liu R, Li X, Zhang Z, Zhou M, Sun Y, Su D, et al. Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep. 2015;5(1):12777.
   PubMedGoogle Scholar
• Liu R, Su D, Zhou M, Feng X, Li X, Sun L, et al. Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjogren's syndrome through the secretion of indoleamine 2, 3-dioxygenase. Rheumatology. 2015;54(2):332–42.
   PubMed Web of Science ®Google Scholar
• Oakes SA, Papa FR. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol. 2015;10:173–94.
   PubMed Web of Science ®Google Scholar
• Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol. 2016;16(8):469–84.
   PubMed Web of Science ®Google Scholar
• Tsang KY, Chan D, Cheslett D, Chan WCW, So CL, Melhado IG, et al. Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol. 2007;5(3):e44.
   PubMed Web of Science ®Google Scholar
• Granados DP, Tanguay P-L, Hardy M-P, Caron E, de Verteuil D, Meloche S, et al. ER stress affects processing of MHC class I-associated peptides. BMC Immunol. 2009;10:10.
   PubMed Web of Science ®Google Scholar
• Qian S-B, Reits E, Neefjes J, Deslich JM, Bennink JR, Yewdell JW, et al. Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol. 2006;177(1):227–33.
   PubMed Web of Science ®Google Scholar
• Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 2015;161(7):1527–38.
   PubMed Web of Science ®Google Scholar
• Grootjans J, Krupka N, Hosomi S, Matute JD, Hanley T, Saveljeva S, et al. Epithelial endoplasmic reticulum stress orchestrates a protective IgA response. Science. 2019;363(6430):993–8.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.
   PubMed Web of Science ®Google Scholar
• Li H, Chen H-Y, Liu W-X, Jia X-X, Zhang J-G, Ma C-L, et al. Prostaglandin E2 restrains human Treg cell differentiation via E prostanoid receptor 2-protein kinase A signaling. Immunol Lett. 2017;191:63–72.
   PubMed Web of Science ®Google Scholar
• Tang Y, Wang B, Sun X, Li H, Ouyang X, Wei J, et al. Rheumatoid arthritis fibroblast-like synoviocytes co-cultured with PBMC increased peripheral CD4+ CXCR5+ ICOS + T cell numbers. Clin Exp Immunol. 2017;190(3):384–93.
   PubMed Web of Science ®Google Scholar
• de Witte SFH, Luk F, Sierra Parraga JM, Gargesha M, Merino A, Korevaar SS, et al. Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells. Stem Cells. 2018;36(4):602–15.
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim J, Saima FT, Rhee K-J, Hwang S, Kim MY, et al. Adipose-derived stem cells ameliorate colitis by suppression of inflammasome formation and regulation of M1-macrophage population through prostaglandin E2. Biochem Biophys Res Commun. 2018;498(4):988–95.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192.
   PubMed Web of Science ®Google Scholar
• Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen A-M, Elgue G, Funke L, et al. Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells. 2012;30(7):1565–74.
   PubMed Web of Science ®Google Scholar
• Marciniak SJ, Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev. 2006;86(4):1133–49.
   PubMed Web of Science ®Google Scholar
• Malhotra JD, Kaufman RJ. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol. 2007;18(6):716–31.
   PubMed Web of Science ®Google Scholar
• Yoshida H. ER stress and diseases. Febs J. 2007;274(3):630–58.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li J, Li L, Liu P, Wei Y, Qian Z. Ceramide enhances COX-2 expression and VSMC contractile hyperreactivity via ER stress signal activation. Vascul Pharmacol. 2017;96–98:26–32.
   PubMed Web of Science ®Google Scholar
• Tong D, Liu Q, Wang LA, Xie Q, Pang J, Huang Y, et al. The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer Metastasis Rev. 2018;37(2–3):355–68.
   PubMed Web of Science ®Google Scholar
• Jiang J, Dingledine R. Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation. J Pharmacol Exp Ther. 2013;344(2):360–7.
   PubMed Web of Science ®Google Scholar
• Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest. 2001;108(1):15–23.
   PubMed Web of Science ®Google Scholar
• Minakuchi R, Wacholtz MC, Davis LS, Lipsky PE. Delineation of the mechanism of inhibition of human T cell activation by PGE2. J Immunol. 1990;145(8):2616–25.
   PubMed Web of Science ®Google Scholar
• van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med. 1995;181(2):775–9.
   PubMed Web of Science ®Google Scholar
• Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y. Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors. Biochim Biophys Acta. 2015;1851(4):414–21.
   PubMed Web of Science ®Google Scholar